P2X3 and/or P2X2/3 receptor antagonist, pharmaceutical composition comprising same, and use thereof
US11414444B2 · kind B2 · utility
1Cited by
0References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 31, 2018 |
| Grant date | Aug 16, 2022 |
| Priority date | — |
| Expiry date | Oct 31, 2038 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07F9/5325
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
A P2X3 and/or P2X2/3 receptor antagonist of formula (I), a pharmaceutical composition comprising the same, and a use thereof in preparing a drag for preventing or treating a disease mediated by the P2X3 and/or P2X2/3 receptor antagonist.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.